• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确定特定人群中新冠病毒易感性和严重程度的风险因素,为未来的个体层面综合风险评分提供依据。

Determining population-specific risk factors for COVID-19 susceptibility and severity to inform future individual-level integrated risk scoring.

作者信息

Morani Ilham, Shibli Haneen, Karasik David, Edelstein Michael

机构信息

The Azrieli Faculty of Medicine, Bar-Ilan University, Safed, 1311502, Israel.

Ziv Medical Center, Safed, 1311502, Israel.

出版信息

BMC Infect Dis. 2025 Aug 4;25(1):977. doi: 10.1186/s12879-025-11357-9.

DOI:10.1186/s12879-025-11357-9
PMID:40760409
Abstract

OBJECTIVES

Acute respiratory tract infections (ARI), including COVID-19, are a significant global health challenge with pandemic potential. Understanding factors influencing ARI susceptibility and severity in different populations is crucial for pandemic preparedness and mitigation. We investigated epidemiological risk factors for COVID-19 susceptibility and severity in the Israeli population.

METHODS

Participants who took a COVID-19 PCR test between July 2021 and August 2022 completed an online survey including demographics, comorbidities, infection and vaccination status. We identified factors associated with SARS-CoV-2 infection and disease severity using logistic regression and compared our results with the global literature.

RESULTS

We included 2128 participants. Of these 823 participants were tested positive for SARS-CoV-2. Individuals without COPD and BMI > 30 had higher infection odds (aOR = 6.21, 95% CI:1.42-27.25 and aOR = 1.54, 95% CI:1.02-2.32; respectively). High school-level education was associated with increased susceptibility and severity compared to higher education (aOR = 1.55, 95% CI:1.1-2.18 and aOR = 2.80, 95% CI 1.62-4.86; respectively). Hospitalization was associated with older age (p < 0.001). Vaccination with 3 doses significantly reduced infection and hospitalization risk compared to unvaccinated (aOR = 0.024, 95% CI:0.016-0.04 and aOR = 0.37, 95% CI: 0.17-0.81; respectively, p < 0.05). Compared to Arab participants, Jewish ones were less likely to be infected (aOR = 1.48, 95% CI:1.02-2.15, p < 0.05).

CONCLUSIONS

Identified risk factors are consistent with meta-analyses of studies from other countries. Similar to other countries, minority groups were found to be at higher risk, therefore risk models predicting ARI susceptibility and severity have to take this into account.

摘要

目的

包括新冠病毒病(COVID-19)在内的急性呼吸道感染(ARI)是一项具有大流行潜力的重大全球健康挑战。了解影响不同人群ARI易感性和严重程度的因素对于大流行防范和缓解至关重要。我们调查了以色列人群中COVID-19易感性和严重程度的流行病学风险因素。

方法

在2021年7月至2022年8月期间进行COVID-19聚合酶链反应(PCR)检测的参与者完成了一项在线调查,内容包括人口统计学、合并症、感染和疫苗接种状况。我们使用逻辑回归确定了与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染和疾病严重程度相关的因素,并将我们的结果与全球文献进行了比较。

结果

我们纳入了2128名参与者。其中823名参与者的SARS-CoV-2检测呈阳性。没有慢性阻塞性肺疾病(COPD)且体重指数(BMI)>30的个体感染几率更高(调整后比值比[aOR]=6.21,95%置信区间[CI]:1.42-27.25;aOR=1.54,95%CI:1.02-2.32;分别)。与高等教育相比,高中水平教育与易感性增加和严重程度增加相关(aOR=1.55,95%CI:1.1-2.18;aOR=2.80,95%CI 1.62-4.86;分别)。住院与年龄较大相关(p<0.001)。与未接种疫苗者相比,接种3剂疫苗显著降低了感染和住院风险(aOR=0.024,95%CI:0.016-0.04;aOR=0.37,95%CI:0.17-0.81;分别,p<0.05)。与阿拉伯参与者相比,犹太参与者感染的可能性较小(aOR=1.48,95%CI:1.02-2.15,p<0.05)。

结论

确定的风险因素与其他国家研究的荟萃分析一致。与其他国家一样,发现少数群体风险较高,因此预测ARI易感性和严重程度的风险模型必须考虑到这一点。

相似文献

1
Determining population-specific risk factors for COVID-19 susceptibility and severity to inform future individual-level integrated risk scoring.确定特定人群中新冠病毒易感性和严重程度的风险因素,为未来的个体层面综合风险评分提供依据。
BMC Infect Dis. 2025 Aug 4;25(1):977. doi: 10.1186/s12879-025-11357-9.
2
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
3
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
6
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.奈玛特韦片/利托那韦片组合包装用于 COVID-19 的预防和治疗。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD015395. doi: 10.1002/14651858.CD015395.pub2.
7
Sero-prevalence of SARS-CoV-2 antibodies in Ethiopia: Results of the National Population Based Survey, 2021.埃塞俄比亚2019冠状病毒病抗体血清流行率:2021年全国人口调查结果
PLoS One. 2025 May 6;20(5):e0313791. doi: 10.1371/journal.pone.0313791. eCollection 2025.
8
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.奈玛特韦/利托那韦片用于 COVID-19 的预防和治疗。
Cochrane Database Syst Rev. 2023 Nov 30;11(11):CD015395. doi: 10.1002/14651858.CD015395.pub3.
9
Laboratory-based molecular test alternatives to RT-PCR for the diagnosis of SARS-CoV-2 infection.基于实验室的分子检测替代 RT-PCR 用于 SARS-CoV-2 感染的诊断。
Cochrane Database Syst Rev. 2024 Oct 14;10(10):CD015618. doi: 10.1002/14651858.CD015618.
10
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.COVID-19 患者使用激素避孕的血栓栓塞风险。
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2.

本文引用的文献

1
The Complex Association between COPD and COVID-19.慢性阻塞性肺疾病(COPD)与2019冠状病毒病(COVID-19)之间的复杂关联。
J Clin Med. 2023 May 31;12(11):3791. doi: 10.3390/jcm12113791.
2
Effectiveness of the pre-Omicron COVID-19 vaccines against Omicron in reducing infection, hospitalization, severity, and mortality compared to Delta and other variants: A systematic review.奥密克戎变异株流行前的 COVID-19 疫苗对降低奥密克戎变异株与德尔塔及其他变异株感染、住院、严重程度和死亡率的有效性:一项系统评价。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2167410. doi: 10.1080/21645515.2023.2167410. Epub 2023 Mar 13.
3
Physical activity and risk of infection, severity and mortality of COVID-19: a systematic review and non-linear dose-response meta-analysis of data from 1 853 610 adults.
身体活动与新型冠状病毒肺炎感染风险、严重程度及死亡率:对1853610名成年人数据的系统评价和非线性剂量反应荟萃分析
Br J Sports Med. 2022 Aug 22. doi: 10.1136/bjsports-2022-105733.
4
The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis.奥密克戎变异株疫苗有效性的系统评价和荟萃分析。
Front Public Health. 2022 Jul 13;10:940956. doi: 10.3389/fpubh.2022.940956. eCollection 2022.
5
COVID-19 vaccination efficacy in numbers including SARS-CoV-2 variants and age comparison: a meta-analysis of randomized clinical trials.COVID-19 疫苗效力的数字分析,包括 SARS-CoV-2 变体和年龄比较:一项随机临床试验的荟萃分析。
Ann Clin Microbiol Antimicrob. 2022 Jul 3;21(1):32. doi: 10.1186/s12941-022-00525-3.
6
Temporal trends of sex differences for COVID-19 infection, hospitalisation, severe disease, intensive care unit (ICU) admission and death: a meta-analysis of 229 studies covering over 10M patients.COVID-19 感染、住院、重症、入住重症监护病房(ICU)和死亡的性别差异的时间趋势:对涵盖超过 1000 万患者的 229 项研究的荟萃分析。
F1000Res. 2022 Jan 5;11:5. doi: 10.12688/f1000research.74645.1. eCollection 2022.
7
Education Attainment, Intelligence and COVID-19: A Mendelian Randomization Study.教育程度、智力与2019冠状病毒病:一项孟德尔随机化研究。
J Clin Med. 2021 Oct 22;10(21):4870. doi: 10.3390/jcm10214870.
8
Disparities in COVID-19 Outcomes by Race, Ethnicity, and Socioeconomic Status: A Systematic-Review and Meta-analysis.COVID-19结局在种族、族裔和社会经济地位方面的差异:一项系统评价和荟萃分析。
JAMA Netw Open. 2021 Nov 1;4(11):e2134147. doi: 10.1001/jamanetworkopen.2021.34147.
9
Lifestyle and Comorbidity-Related Risk Factors of Severe and Critical COVID-19 Infection: A Comparative Study Among Survived COVID-19 Patients in Bangladesh.重症和危重症新型冠状病毒肺炎感染的生活方式及合并症相关危险因素:孟加拉国新冠肺炎康复患者的比较研究
Infect Drug Resist. 2021 Sep 30;14:4057-4066. doi: 10.2147/IDR.S331470. eCollection 2021.
10
Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients.COVID-19 相关死亡风险因素:42 项研究和 423117 例患者的系统评价和荟萃分析。
BMC Infect Dis. 2021 Aug 21;21(1):855. doi: 10.1186/s12879-021-06536-3.